These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15123119)

  • 41. Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years.
    Liao SF; Lee WC; Chen HC; Chuang LC; Pan MH; Chen CJ
    Cancer Causes Control; 2012 May; 23(5):703-8. PubMed ID: 22450735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papilloma virus (HPV) molecular diagnostics.
    Kroupis C; Vourlidis N
    Clin Chem Lab Med; 2011 Nov; 49(11):1783-99. PubMed ID: 21875401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of high-risk human papillomavirus infections in healthy Saudi women attending gynecologic clinics in the western region of Saudi Arabia.
    Bondagji NS; Gazzaz FS; Sait K; Abdullah L
    Ann Saudi Med; 2013; 33(1):13-7. PubMed ID: 23458934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cervical screening in the era of HPV vaccination.
    Farnsworth A
    Cytopathology; 2010 Aug; 21(4):211-2. PubMed ID: 20646019
    [No Abstract]   [Full Text] [Related]  

  • 45. HPV testing in cervical cytology practice: it's all about choice.
    Stoler MH
    Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
    [No Abstract]   [Full Text] [Related]  

  • 46. HPV test: antidote to ASCUS headache?
    Titus K
    CAP Today; 1996 Sep; 10(9):1, 52-4, 56-8. PubMed ID: 10166422
    [No Abstract]   [Full Text] [Related]  

  • 47. [Is the HPV test to supplement vaginal smears in menopausal women?].
    Gustavsson I; Gyllensten U; Lindell M; Wilander E
    Lakartidningen; 2010 Feb 24-Mar 2; 107(8):528-9. PubMed ID: 20384066
    [No Abstract]   [Full Text] [Related]  

  • 48. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Juschenko A; Tosi P; Syrjänen K;
    Int J STD AIDS; 2005 Mar; 16(3):217-23. PubMed ID: 15835076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 21-year-old woman with atypical squamous cells of undetermined significance.
    Sawaya GF
    JAMA; 2005 Nov; 294(17):2210-8. PubMed ID: 16264163
    [No Abstract]   [Full Text] [Related]  

  • 50. Screening for cervical cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2003 Nov; 103(11):101-2, 105-6, 108-9. PubMed ID: 14625432
    [No Abstract]   [Full Text] [Related]  

  • 51. Human papillomavirus testing for primary cervical cancer screening.
    Runowicz CD; Garozzo S
    Curr Oncol Rep; 2008 Nov; 10(6):533-7. PubMed ID: 18928670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus detection in pregnant women: a prospective matched cohort study.
    Schmeink CE; Melchers WJ; Hendriks JC; Quint WG; Massuger LF; Bekkers RL
    J Womens Health (Larchmt); 2012 Dec; 21(12):1295-301. PubMed ID: 23210493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus infections: truth or consequences.
    Monk BJ; Wiley DJ
    Cancer; 2004 Jan; 100(2):225-7. PubMed ID: 14716754
    [No Abstract]   [Full Text] [Related]  

  • 54. Image-guided ThinPrep Papanicolaou tests and cotesting with high-risk human papillomavirus in women aged 30 years and older in a low-risk private practice population.
    Ge Y; Smith D; Schwartz MR; Mody DR
    Cancer; 2009 Oct; 117(5):326-32. PubMed ID: 19711471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Could urine testing be the future of cervical cancer screening?
    Pathak N; Dodds J; Zamora J
    Womens Health (Lond); 2015 Jun; 11(3):265-7. PubMed ID: 26102464
    [No Abstract]   [Full Text] [Related]  

  • 56. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
    Belinson SE; Belinson JL
    Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathology of the Cervix. Introduction to the focal topic "Pathology of the cervix - future developments"].
    Heinzl S
    Gynakol Geburtshilfliche Rundsch; 2004 Jun; 44(3):129-30. PubMed ID: 15211057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.
    Poljak M; Brencic A; Seme K; Vince A; Marin IJ
    J Clin Microbiol; 1999 Mar; 37(3):796-7. PubMed ID: 9986857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ongoing vaccination program against cervix cancer is based on HPV test].
    Rubinstein E
    Lakartidningen; 2002 Dec; 99(50):5116. PubMed ID: 12572309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.